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Because of its location, most parts of South Africa (SA) have high 
levels of solar ultraviolet radiation (UVR).[1] Despite its geographical 
size, the Northern Cape (NC) Province has the smallest population 
of the provinces in SA, with only 1.18 million inhabitants, of whom 
50.4% are black, 40.3% coloured, 7.1% white, 0.7% Indian/Asian and 
1.5% other.[2,3] Its economy relies mainly on mining and agriculture, 
and almost one-fifth of the currently employed NC population work 
outdoors in the agricultural industry.[4] Approximately 90% of non-
melanoma skin cancer (NMSC) is attributable to personal UVR 
exposure, so South Africans are especially susceptible to skin cancer 
owing to their year-round exposure to high ambient solar UVR.[5] 
Individuals working in outdoor occupations are at an even greater risk 
of NMSC, as they are likely to be outside for more daylight hours. [6,7] 
SA has one of the world’s largest HIV epidemics,[8] with infected 
individuals having a 3 - 5-fold and 50-fold increased risk of developing 
NMSC and HIV-associated Kaposi’s sarcoma (KS), respectively.[9]
The incidence of NMSC and cutaneous malignant melanoma 
(CMM) is increasing globally, so reporting systems to monitor 
numbers of cases and trends over time are essential.[10,11] However, 
owing to limited private sector submissions to the National Cancer 
Registry (NCR) the last comprehensive data inclusive of all health 
sectors were published in 2004, making it difficult to establish 
whether skin cancer incidence in SA has followed the global trend.[12]
In 2011, the SA National Department of Health passed a 
regulation[13] that made cancer a reportable disease, requiring that all 
histologically confirmed cases be reported to the NCR.[14] Concerns 
have been raised that if the incidence of skin cancer continues to 
rise unchecked, it may become a major health problem and place 
a large financial burden on private and public health services.[15] 
Of additional concern is that melanomas of a depth >4 mm carry a 
high risk of mortality.[16] As tumour thickness provides an indication 
of how early a melanoma has been detected, monitoring trends in 
melanoma thickness to assess whether thinner melanomas are being 
detected may be appropriate.[17]
Objective
To describe the nature and extent of different types of histologically 
confirmed skin cancers presenting in the public and private health 
sectors of the NC to provide insight into the local skin cancer burden 
in SA.
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Background. Excessive sun exposure and a high prevalence of HIV increase skin cancer risk in South Africa (SA).
Objective. To describe the nature and extent of skin cancers presenting in the public and private health sectors of the Northern Cape 
Province of SA.
Methods. A retrospective analysis of histologically confirmed new primary cutaneous malignancies from 1 January 2008 to 31 December 
2012 was conducted using public and private health sector databases. Types, quantity and distribution of common invasive malignancies by 
population group, age, gender, anatomical site and health sector were explored. One-year cumulative incidence was calculated and logistic 
regression models were used to analyse incidence and melanoma thickness trends.
Results. A total of 4 270 biopsies (13 cutaneous malignancies) were identified. The commonest was squamous cell carcinoma (SCC), 
followed by basal cell carcinoma, Kaposi’s sarcoma (KS), cutaneous malignant melanoma (CMM) and basosquamous carcinoma, in 
descending order. The odds of a white male developing SCC increased by 8% each year (odds ratio (OR) 1.08, 95% confidence interval 
(CI) 1.01 - 1.15; p=0.022), while the odds of a black male developing SCC and KS decreased by 9% (OR 0.91, 95% CI 0.84 - 0.99; p=0.033) 
and 18% (OR 0.82, 95% CI 0.70 - 0.97; p=0.022), respectively, each year. SCC and CMM were diagnosed at more advanced stages in the 
public than in the private healthcare sector. CMM is being detected earlier, as indicated by low-stage depth increasing by 72% annually (OR 
1.72, 95% CI 1.04 - 3.01; p=0.042).
Conclusions. Results suggest that reported skin cancer patterns are changing. There is a need for further research and equitable 
appropriation of financial resources and effort towards developing primary skin cancer prevention initiatives in SA.
S Afr Med J 2017;107(1):83-88. DOI:10.7196/SAMJ.2017.v107i1.10924
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Methods
A retrospective chart review of histologically confirmed new primary 
cutaneous malignancies from 1 January 2008 to 31 December 2012 
was conducted. Different types of skin cancer, numbers of each 
and the distribution of the five commonest invasive malignancies 
by population group, age, gender, anatomical site and health sector 
were explored. The incidences of the five most common invasive 
malignancies and their trends over 5 years were calculated. Trends in 
melanoma thickness were analysed.
Skin biopsies from public facilities in the NC are sent to the 
National Health Laboratory Service histopathology laboratory, 
while those from private facilities are sent to PathCare or Ampath 
laboratories. Data on all incident cases were extracted by performing 
a Systemised Nomenclature of Medicine (SNOMED) search of the 
Laboratory of Data Intensive Systems and Applications (DISA), 
PathCare and Ampath databases, using the SNOMED codes for all 
cutaneous malignancies. The data extracted from the histopathology 
reports for each patient included the date, histopathological diagnosis, 
population group, gender, age, anatomical site of the lesion and health 
sector. The study was conducted in accordance with ethical principles 
contained in the Declaration of Helsinki.[18] It was approved by the 
Faculty of Health Sciences Ethics Committee of the University of 
Cape Town (HREC/REF: 357/2015).
All histologically confirmed new primary cutaneous malignancies 
in public and private sector paediatric and adult patients from towns 
in the NC between the study dates were eligible to be included. 
Exclusion criteria included new primary cutaneous malignancies 
that were not incident cases, cutaneous metastases, squamous cell 
carcinoma (SCC) of the tongue, palate, buccal mucosa, vagina and 
anus, and KS of the tonsil, tongue, larynx and nasopharynx.
Statistical analysis
Before analysing the data, the Data Management and Statistical 
Analysis Unit of the University of the Witwatersrand, Johannesburg, 
used a hot-deck imputation method to correlate cases with no 
population group against a reference database containing surnames 
with a known population group. This enabled each patient’s 
population group to be estimated, as was done by the NCR in 1998 
when it faced a similar dilemma. The method proved to be accurate, 
and its results compared well with previous registry statistics.[19-21]
For the primary analysis, two software packages were used, namely 
SPSS Statistics version 21 (IBM, USA) and R version 3.1.3, 64-bit 
version (R Foundation for Statistical Computing, Austria). The 
statistical analysis was divided into three components.
The first component involved establishing the main types of skin 
cancer according to patient demographic and histological data. 
Empirical descriptive statistics were calculated. The Kruskal-Wallis 
test for similarities in age distribution between different types of 
cutaneous malignancies was performed because the data were not 
normally distributed.
The second component involved calculating the incidences of the 
five most common cutaneous malignancies for each year. Throughout 
this article, incidence refers to yearly cumulative incidence, i.e. the 
proportion of those at risk who acquire cancer over a 1-year period. 
The incidence of each malignancy was calculated using the total 
number of new histologically confirmed cases of a skin cancer type in 
a particular year as the numerator, with the NC mid-year population 
estimate for the year as the denominator. This was reported as 
incidence per 100 000 per year.
The third component investigated trends in incidence and melanoma 
thickness over the 5 years. Logistic regression modelling was used to 
estimate annual incidence trends controlling for potential confounders. 
The Hochberg procedure was used to adjust for multiple comparisons. 
The level of significance was set at a two-sided p-value (p<0.05). To 
investigate trends in melanoma thickness over 5 years, Clark’s staging 
data were collapsed into ‘high-stage’ and ‘low-stage’ categories for 
analysis, ‘low stage’ being Clark levels 1 and 2 and ‘high stage’ Clark 
levels 3 - 5. Odds ratios (ORs) for a low stage were estimated using 
logistic regression modelling adjusted for potential confounders.
Results
A total of 4 270 biopsies comprising 13 cutaneous malignancies were 
identified. The five most common invasive malignancies made up 
82.7% of all the cases. In descending order they were SCC, basal cell 
carcinoma (BCC), KS, CMM and basosquamous carcinoma (BSC) 
(Table 1).
Demographics of the five most common invasive  
skin cancers
Of the patients, 2 093 (52.0%) were white, 1 047 (26.0%) black, 864 
(21.4%) coloured and 23 (0.6%) Indian/Asian. Imputed population 
group was unspecified in 243 patients. BCC, CMM and BSC occurred 
relatively more frequently in white individuals than in other population 
groups. A high rate of SCC was observed in white, black and coloured 
individuals. KS occurred more commonly in the black population (Fig. 1).
The male/female ratio was 1:1 (2 108 males, 2 095 females). 
Gender was unspecified in 67 patients. All five of the most common 
invasive cutaneous malignancies affected males more frequently than 
females, with BSC occurring twice as often in males. Squamous cell 
carcinoma in situ (SCCI) represented the major exception to this 
trend, occurring six times more frequently in females (Fig. 2).
Age range spanned 2 - 101 years (mean 51.6). There was a 
statistically significant difference in age distribution between 
malignancies (p<0.001). BCC occurred most frequently in the age 
group 60 - 69 years, while CMM and SCC presented most commonly 
in those aged 50 - 59 years and BSC in those aged 70 - 79 years. The 
majority of KSs occurred in the younger age group 30 - 39 years.
Table 1. Skin cancer spectrum and distribution
Skin cancer types n (%)
Squamous cell carcinoma 1 938 (45.4)
Basal cell carcinoma 1 185 (27.8)
Squamous cell carcinoma in situ 667 (15.6)
Kaposi’s sarcoma 276 (6.5)
Cutaneous malignant melanoma 135 (3.1)
Basosquamous carcinoma 43 (1.0)
Dermatofibrosarcoma protuberans 13 (0.3)
Mycosis fungoides 3 (0.07)
Sebaceous adenocarcinoma 3 (0.07)
Trichilemmal carcinoma 3 (0.07)
Angiocentric T-cell lymphoma 2 (0.05)
Merkel cell carcinoma 1 (0.02)
Mucinous carcinoma 1 (0.02)
Total 4 270 (100)
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Head and neck regions were the most common anatomical sites 
affected by BCC, SCC and BSC. CMM occurred most commonly on 
the lower limbs.
Of the 4 270 biopsies, 2 448 (57.3%) and 1 822 (42.7%) were from 
the public and private healthcare sectors, respectively. In decreasing 
order of frequency, BCC, SCC and CMM were most common in 
the private sector, while SCC followed by KS accounted for the 
majority of the pathology in the public sector (Fig. 3). Ninety percent 
(n=1 061) of the BCCs occurred in private sector patients, while 
73.1% (n=1 417) of SCCs identified were from the public sector. Of 
the 101 patients with CMM, 62.4% (n=63) were from the private 
sector while 37.6% (n=38) were from the public sector. Of the private 
sector patients 83.7% were white, while in the public sector 27.3% 
were white, 43.0% black and 28.9% coloured (Table 2).
Of the invasive SCCs, 1 524 (78.6%) could be categorised according 
to tumour differentiation. Of these, 20.9% were well differentiated, 
while 58.9.% were moderately differentiated and 20.2% were poorly 
differentiated. In both the coloured and black populations, almost a 
quarter of malignancies were poorly differentiated.
Incidence and 5-year incidence trends
Table 3 reports the incidence of the five most common invasive 
cutaneous malignancies (/100 000) from 2008 to 2012, as well as 
the estimated ORs of each cancer for a 1-year increase. Incidence 
was then plotted and logistic regression was used to model trends. 
Categories marked with an asterisk in Table 3 are those in which a 
significant trend (p<0.05) was seen (Fig. 4).
The odds of a black male developing KS or SCC decreased by 
18% (OR 0.82, 95% confidence interval (CI) 0.70 - 0.97; p=0.0222) 
and 9% (OR 0.91, 95% CI 0.84 - 0.99; p=0.0336), respectively, every 
year over the 5-year period. In contrast, the odds of a white male 
developing BSC or SCC increased by 45% (OR 1.45, 95% CI 1.08 - 
1.99; p=0.0177) and 8% (OR 1.08, 95% CI 1.01 - 1.15; p=0.0225), 
respectively. Once the Hochberg procedure was applied, significant 
trends in incidence were not observed.
Trends in melanoma thickness
Of CMMs, 55.4% were not subtyped and 25.7% were still in the 
in situ phase at the time of excision. Acral lentiginous melanoma 
(ALM) was the subtype that occurred most frequently, and all 
cases of this subtype occurred in the public sector. Clark level for 
CMM in the private sector ranged from 1 to 4 (mean 2.7), while 
Table 2. Population group distribution in the private and 
public sectors
Population group* Private sector, n (%) Public sector, n (%)
Black 71 (4.0) 976 (43.0)
Coloured 209 (11.9) 655 (28.9)
Indian 5 (0.3) 18 (0.8)
White 1 473 (83.7) 620 (27.3)
Total 1 758 (100) 2 269 (100)
*Imputed population group unspecified for 64 and 179 patients in the private and public 
sectors, respectively.
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Fig. 4. Significant changes in incidence trends, 2008 - 2012.
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in the public sector it ranged from 2 to 5 (mean 4.2). Only in 2012 
were no cases with a Clark level 5 seen. Once Clark’s staging data 
were collapsed into low and high stages and a logistic regression 
model was applied, the OR for low-stage depth for every 1-year 
increase from 2009 to 2012 was estimated to be 1.72 (95% CI 1.04 - 
3.01; p=0.0429). This indicates that the odds of a low-stage depth 
increased by 72% from one year to the next, confirming that CMM 
is being detected earlier.
Discussion
SCC, BCC, KS and CMM were the four most frequently occurring 
skin cancers in the NC, in accordance with the 2004 national 
statistics published by the NCR.[22] SCC was the most frequent 
cutaneous malignancy seen between 2008 and 2012, and high rates 
were observed in the white, black and coloured population groups. 
The incidence of SCC has risen worldwide over the past several 
decades, at an estimated 3 - 10% per year.[23] The vast majority of 
NMSC is attributed to personal UVR exposure, and SA is located 
in the southern hemisphere, which has a greater intensity of UVR 
than northern hemisphere sites at a similar latitude.[1,24] Another 
contributor may be that 18.5% of the currently employed NC 
population works in the agricultural industry,[4] which is more 
than double the proportion of the population doing so in any other 
province. Individuals who work outdoors have a 43% and 77% 
increased risk of BCC and SCC, respectively.[6,7] In addition, the 
prevalence of HIV infection in the NC in 2011 was 17%,[25] and 
individuals with this disease have an increased risk of developing 
NMSC.[8] The HIV status of the patients included in this study was 
Table 3. Incidence of malignancies from 2008 to 2012 and estimated ORs for a 1-year time increase
Cancer Gender Race
Incidence, 100 000/year OR p-values
2008 2009 2010 2011 2012 Est.
95% CI 
LL
95% CI
UL Adj. Unadj.
SCC  F B 19 19.6 13.8 18.5 15.6 0.96 0.88 1.04 0.9852 0.2787
C 17.3 19.7 19.7 34.6 16 1.05 0.96 1.15 0.9852 0.2731
W 142.2 143.4 145.2 186.6 115 1 0.92 1.08 0.9852 0.9429
 M B 18.3 21.9 17.5 17.1 12.6 0.91* 0.84* 0.99* 0.9074* 0.0336*
C 19.2 24.8 23.4 21.35 23.5 1.02 0.93 1.12 0.9852 0.6523
W 215 158.3 230 248.7 248 1.08* 1.01* 1.15* 0.6308* 0.0225*
BCC  F B 0.3 0.6 1.47 0.84 0.63 1.13 0.76 1.70 0.9852 0.5456
C 5.7 3.9 4.8 6.9 6.1 1.06 0.89 1.27 0.9852 0.4851
W 157.7 108.6 166.6 171.1 185 1.08 1 1.16 0.9852 0.0532
 M B 2.1 1.8 1.6 1.86 2.9 1.09 0.85 1.41 0.9852 0.5189
C 6.1 8.9 6.3 11.9 8.3 1.09 0.94 1.27 0.9852 0.2709
W 295 208 327.5 346.1 295 1.05 0.99 1.11 0.9852 0.0756
KS  F B 3.93 4.22 4.12 2.53 2.22 0.86 0.71 1.04 0.9852 0.1138
C 4 2.63 2.4 2.47 1.29 0.80 0.60 1.46 0.9852 0.0998
W 8.19 4.34 7.14 8.19 7.5 1.03 0.72 1.46 0.9852 0.8858
 M B 5.98 7.55 2.93 5.59 2.26 0.82* 0.70* 0.97* 0.6308* 0.0222*
C 3.55 1.87 2.44 7.29 2.3 1.08 0.85 1.37 0.9852 0.5243
W 12.5 6.25 12.5 7.69 9.75 0.97 0.70 1.32 0.9852 0.8328
CMM  F B 0.61 0.60 0.58 0.28 0.63 0.95 0.58 1.52 0.9852 0.8186
C 0.44 0.43 1.92 0 0.43 0.94 0.54 1.59 0.9852 0.8107
W 11.1 4.34 14.2 4.4 25 1.26 0.95 1.70 0.9852 0.1130
 M B 0.35 0.35 0 0.31 0 0.68 0.24 1.55 0.9852 0.3836
C 1.01 2.81 1.95 1.04 0.46 0.81 0.55 1.16 0.9852 0.2578
W 12.5 16.6 15 17.9 17.1 1.07 0.83 1.36 0.9852 0.6109
BSC  F B 0 0.3 0 0 0 0.56 0.04 2.54 0.9852 0.5037
C 0.44 0 0.48 0 0 0.58 0.17 1.35 0.9852 0.2631
W 2.22 2.17 9.5 2.22 5 1.15 0.72 1.88 0.9852 0.5620
 M B 0 0 0 0.62 0 1.72 0.60 8.83 0.9852 0.3730
C 0.51 0 0 0 0.46 0.99 0.34 2.89 0.9852 0.9852
W 5 6.25 12.5 12.8 21.9 1.45* 1.08* 1.99* 0.5299* 0.0177*
The Hochberg procedure was used to adjust for multiple comparisons. This step-up procedure may result in a number of adjusted p-values being of the same value and as implemented in the 
R function ‘adjust p’.
Est. = estimated OR; 95% CI LL = 95% CI lower limit; 95% CI UL = 95% CI upper limit; Adj. = adjusted p-value; Unadj. = unadjusted p-value; F = female; M = male; B = black; C = coloured;  
W = white.
*Categories marked with an asterisk are those in which a significant trend (p<0.05) was seen.
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unknown, but infection with the virus may have contributed to the 
high observed SCC incidence.
SCC and BCC tend to occur more frequently in males,[26] and 
this study found this observation to be true (male/female ratio 1.1:1 
for SCC and 1.7:1 for BCC). Approximately 75% of SCCI occurs in 
women,[27] but an even higher rate (87.0%) was seen here.
A sharp increase in BCC incidence was seen in the age group 
>60  years. The majority of SCC developed in a younger age group 
(50 - 59 years) than that in which it is normally seen.[26] The SA 
data from 2000 to 2004 found SCC in the black population also 
to be developing about 10 years earlier.[28] HIV infection and the 
large percentage of the NC population working outdoors in the 
agricultural industry from a young age were likely to have contributed 
to the earlier presentation of SCC observed in this study. The KSs 
observed were probably of the AIDS-related type, hence KS was used 
as a proxy for HIV status. The 2012 South African National HIV 
Prevalence, Incidence and Behaviour Survey[29] found that females 
aged 30 - 34 years and males aged 35 - 39 years had the highest HIV 
infection rates, so it is not surprising that the incidence of KS in our 
study peaked in the age group 30 - 39 years.
The population group distribution in each health sector is likely to 
have influenced the range of malignancies seen within them. White 
individuals made up the majority of private sector patients, and it 
can be assumed that they would have a skin type I, II or III on the 
Fitzpatrick phototype classification scale.[30] This may explain the 
predominant pathology seen the private sector, which in decreasing 
order included BCC, SCC and CMM. Black patients made up nearly 
half of public sector patients. SCC and KS are reportedly the most 
common cutaneous malignancies in black individuals, which may 
explain why these pathologies accounted for most skin cancer in the 
public sector.[31,32]
Poorly differentiated SCC occurred in a higher percentage of black 
and coloured individuals than white individuals. Poorly differentiated 
subtypes have a poorer prognosis and tend to be seen in patients who 
have presented late, once the tumour is already advanced.[33] An 
explanation for the high frequency of this subtype in individuals with 
dark skins may be their lower perceived risk of skin cancer.
Between 2008 and 2012, the odds of a black male developing 
KS or SCC decreased significantly. A possible explanation for this 
decline may be that the roll-out of antiretroviral therapy (ART) in 
the NC only commenced in July 2004, at which time only 6.6% of 
HIV-positive patients requiring ART were receiving it.[34] In contrast, 
by 2008, 90.4% of these individuals were receiving ART.[34] Most 
of the increase in CD4 count after starting ART occurs in the first 
3  years. [35] As the incidence of both SCC and KS is influenced by 
HIV and immune status, improvement in many individuals’ immune 
status following ART initiation after 2004 may explain the declining 
rates of these pathologies a few years later.[9] The rising incidences of 
BCC and SCC among white males between 2008 and 2012 concur 
with a recent systematic review of the global incidence of NMSC, 
which found an increase in its incidence in white populations 
worldwide.[10]
No significant trend in the incidence of CMM was seen in 
any race or gender group between 2008 and 2012. ALM was 
the subtype most commonly observed, all cases occurred in the 
public sector, and the majority were of an advanced depth (mean 
Breslow depth 4.13 mm). A Breslow depth of ≥4 mm implies a 
5-year survival rate of 37 - 50%. [16] ALMs are often diagnosed 
at an advanced stage because it is difficult to distinguish them 
from ethnic pigmentation or traumatic skin changes. In addition, 
most practitioners have an increased threshold for performing 
biopsies in acral sites owing to associated delayed healing times 
and morbidity. CMMs in the public sector were diagnosed at a 
more advanced stage. Socioeconomic factors influence disease 
outcomes in CMM, and less affluent groups generally have more 
advanced disease and poorer survival rates.[36] In addition to the 
abovementioned factors, longer waiting times for appointments 
in the public sector may impact on late diagnosis. Tumour 
thickness is an indicator of the effectiveness of early detection of 
melanomas,[17] and in many countries there is an ongoing trend 
towards earlier detection and therefore thinner melanomas being 
discovered, as well as an increase in the percentage of melanoma 
in situ diagnosed.[17] The fact that one-quarter of melanomas in 
our study were still in the in situ phase at the time of excision, and 
that the odds of a low-stage depth were found to increase from one 
year to the next, confirmed that CMMs in the NC are also being 
detected at an earlier stage.
Study limitations
Study limitations included using only histologically confirmed cases 
of skin cancer. Some malignancies (e.g. BCC or KS) may have been 
diagnosed on the basis of characteristic clinical features and treated 
without histological confirmation, resulting in underestimation of 
the true cumulative incidence. The sparsely populated NC is a large 
province, and is bordered by Namibia, Botswana, and other provinces 
of SA.[37] It is possible that some individuals may have sought treatment 
for suspicious skin lesions in other countries or provinces, and this 
may have led to skewing of the figures. HIV status of participants 
in the study was unknown. As HIV increases the risk of developing 
an NMSC,[9] this may have influenced the incidence of NMSC 
observed. Very little patient history was supplied on the majority of 
histopathology request forms, and this was a limitation with regard to 
SCC, as it was not possible to tell whether the malignancy had arisen 
in a scar or chronic ulcer or on sun-exposed skin. There are no NC 
skin cancer statistics to refer to or compare with, so comparisons with 
previous national skin cancer statistics had to be made.
Conclusions
This is the first SA study to collate and analyse public and private 
sector skin cancer data for an entire province. These data give 
insight into the skin cancer burden faced by the NC and provide 
a basis for future monitoring of skin cancer incidence. They 
also supply a framework to measure effectiveness of skin cancer 
prevention programmes in the province. Skin cancer patterns in 
SA are changing. There is a need for equitable appropriation of 
greater financial resources and effort towards developing primary 
prevention initiatives tailored to an SA context, in order to curb 
further increases in skin cancer incidence.
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